Yahoo

Mail

UK markets closed

NIKKEI 225
38,385.73
+29.67(+0.08%)
HANG SENG
19,073.71
-41.35(-0.22%)
CRUDE OIL
78.84
+0.82(+1.05%)
GOLD FUTURES
2,393.20
+33.30(+1.41%)
DOW
39,908.00
+349.89(+0.88%)
Bitcoin GBP
52,042.25
+3,493.90(+7.20%)

Money

How to claim expenses at work without breaking the rules

Knowing more about tax rules can save you money

Medpace Holdings, Inc. (MEDP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

405.88

+7.36

(+1.85%)

At close: 04:00PM EDT

405.88

0.00

(0.00%)

After hours:

04:20PM EDT

Major holders

Insider roster

Insider transactions

Currency in USD

Insider purchases - Last 6 months	Shares	Trans
Purchases	60,957	13
Sales	2,503,360	40
Net shares purchased (sold)	-2,442,403	53
Total insider shares held	5.52M	N/A
% net shares purchased (sold)	-30.70%	N/A

Net institutional purchases - Prior quarter to latest quarter	Shares
Net shares purchased (sold)	N/A
% change in institutional shares held	N/A

Insider transactions reported - last two years

Insider	Transaction	Type	Value	Date	Shares
TROENDLE AUGUST J Chief Executive Officer	Sale at price 402.89 per share.	Direct	1,996,723	10 May 2024	4,956
TROENDLE AUGUST J Chief Executive Officer	Sale at price 400.17 - 400.58 per share.	Direct	3,310,566	09 May 2024	8,268
TROENDLE AUGUST J Chief Executive Officer	Sale at price 401.73 - 404.48 per share.	Direct	21,129,347	07 May 2024	52,404
TROENDLE AUGUST J Chief Executive Officer	Sale at price 400.44 - 401.56 per share.	Direct	6,553,671	02 May 2024	16,330
TROENDLE AUGUST J Chief Executive Officer	Sale at price 400.31 - 400.69 per share.	Direct	6,782,987	30 Apr 2024	16,930
KRAFT ROBERT O Director		Direct		28 Mar 2024	72
CARLEY BRIAN T Director		Direct		28 Mar 2024	79
MCCARTHY CORNELIUS P. III Director		Direct		28 Mar 2024	63
BURWIG SUSAN ELIZABETH Officer	Sale at price 403.00 per share.	Direct	41,106	15 Mar 2024	102
KEATING ASHLEY M. Director	Sale at price 409.87 per share.	Direct	102,468	14 Mar 2024	250
KEATING ASHLEY M. Director	Conversion of Exercise of derivative security at price 84.36 per share.	Direct	42,180	14 Mar 2024	500
TROENDLE AUGUST J Chief Executive Officer	Sale at price 408.71 - 412.98 per share.	Indirect	82,321,250	08 Mar 2024	200,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 408.71 - 412.98 per share.	Direct	82,321,250	08 Mar 2024	200,000
KEATING ASHLEY M. Director	Sale at price 415.00 per share.	Direct	195,880	07 Mar 2024	472
KEATING ASHLEY M. Director	Conversion of Exercise of derivative security at price 54.99 per share.	Direct	25,955	07 Mar 2024	472
TROENDLE AUGUST J Chief Executive Officer	Sale at price 402.70 - 403.12 per share.	Indirect	40,291,000	05 Mar 2024	100,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 402.70 - 403.12 per share.	Direct	40,291,000	05 Mar 2024	100,000
GEIGER JESSE J President	Conversion of Exercise of derivative security at price 90.65 per share.	Direct	3,626,000	05 Mar 2024	40,000
GEIGER JESSE J President	Sale at price 403.03 per share.	Direct	8,996,033	04 Mar 2024	22,321
TROENDLE AUGUST J Chief Executive Officer	Sale at price 393.71 - 401.88 per share.	Indirect	40,024,600	01 Mar 2024	100,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 393.71 - 401.88 per share.	Direct	40,024,600	01 Mar 2024	100,000
EWALD STEPHEN P General Counsel	Sale at price 393.50 - 400.79 per share.	Direct	597,923	01 Mar 2024	1,513
GEIGER JESSE J President	Sale at price 393.50 per share.	Direct	1,006,586	29 Feb 2024	2,558
TROENDLE AUGUST J Chief Executive Officer	Sale at price 401.88 - 404.13 per share.	Indirect	40,300,500	28 Feb 2024	100,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 401.88 - 404.13 per share.	Direct	40,300,500	28 Feb 2024	100,000
KEATING ASHLEY M. Director	Sale at price 405.00 per share.	Direct	202,500	28 Feb 2024	500
KEATING ASHLEY M. Director	Conversion of Exercise of derivative security at price 54.99 per share.	Direct	27,495	28 Feb 2024	500
TROENDLE AUGUST J Chief Executive Officer	Sale at price 400.32 - 402.38 per share.	Indirect	62,938,689	26 Feb 2024	156,928
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 400.32 - 402.38 per share.	Direct	62,938,689	26 Feb 2024	156,928
KEATING ASHLEY M. Director	Sale at price 403.89 - 404.68 per share.	Direct	202,147	26 Feb 2024	500
KEATING ASHLEY M. Director	Conversion of Exercise of derivative security at price 54.99 per share.	Direct	27,495	26 Feb 2024	500
TROENDLE AUGUST J Chief Executive Officer	Sale at price 383.44 - 395.98 per share.	Indirect	53,406,441	22 Feb 2024	136,012
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 383.44 - 395.98 per share.	Direct	53,406,441	22 Feb 2024	136,012
TROENDLE AUGUST J Chief Executive Officer	Sale at price 386.39 - 391.75 per share.	Indirect	24,992,323	20 Feb 2024	63,988
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 386.39 - 391.75 per share.	Indirect	24,992,323	20 Feb 2024	63,988
CARLEY BRIAN T Director	Conversion of Exercise of derivative security at price 26.44 per share.	Direct	364,396	20 Feb 2024	13,782
MCCARTHY CORNELIUS P. III Director	Conversion of Exercise of derivative security at price 57.17 per share.	Direct	269,271	08 Feb 2024	4,710
KRAFT ROBERT O Director		Direct		29 Dec 2023	94
CARLEY BRIAN T Director		Direct		29 Dec 2023	103
MCCARTHY CORNELIUS P. III Director		Direct		29 Dec 2023	82
BURWIG SUSAN ELIZABETH Officer	Sale at price 303.00 - 304.15 per share.	Direct	3,769,150	15 Dec 2023	12,400
TROENDLE AUGUST J Chief Executive Officer	Sale at price 272.18 - 273.26 per share.	Indirect	14,507,101	01 Dec 2023	53,167
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 272.18 - 273.26 per share.	Direct	14,507,101	01 Dec 2023	53,167
TROENDLE AUGUST J Chief Executive Officer	Sale at price 273.66 - 276.10 per share.	Indirect	12,877,319	28 Nov 2023	46,833
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 273.66 - 276.10 per share.	Direct	12,877,319	28 Nov 2023	46,833
TROENDLE AUGUST J Chief Executive Officer	Sale at price 277.81 per share.	Indirect	6,945,250	22 Nov 2023	25,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 277.81 per share.	Direct	6,945,250	22 Nov 2023	25,000
TROENDLE AUGUST J Chief Executive Officer	Sale at price 277.37 per share.	Indirect	6,934,250	21 Nov 2023	25,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 277.37 per share.	Direct	6,934,250	21 Nov 2023	25,000
TROENDLE AUGUST J Chief Executive Officer	Sale at price 273.91 - 275.45 per share.	Indirect	27,468,000	20 Nov 2023	100,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 273.91 - 275.45 per share.	Direct	27,468,000	20 Nov 2023	100,000
TROENDLE AUGUST J Chief Executive Officer	Sale at price 281.61 - 283.42 per share.	Indirect	21,217,980	16 Nov 2023	75,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 281.61 - 283.42 per share.	Direct	21,217,980	16 Nov 2023	75,000
BURWIG SUSAN ELIZABETH Officer	Conversion of Exercise of derivative security at price 32.05 per share.	Direct	240,375	23 Oct 2023	7,500
KRAFT ROBERT O Director		Direct		29 Sept 2023	94
CARLEY BRIAN T Director		Direct		29 Sept 2023	103
MCCARTHY CORNELIUS P. III Director		Direct		29 Sept 2023	82
TROENDLE AUGUST J Chief Executive Officer	Sale at price 244.27 - 255.48 per share.	Indirect	31,833,495	21 Sept 2023	127,308
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 244.27 - 255.48 per share.	Direct	31,833,495	21 Sept 2023	127,308
TROENDLE AUGUST J Chief Executive Officer	Sale at price 259.66 - 274.76 per share.	Indirect	50,339,894	19 Sept 2023	190,764
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 259.66 - 274.76 per share.	Direct	50,339,894	19 Sept 2023	190,764
KRAFT ROBERT O Director	Sale at price 265.67 per share.	Direct	3,661,464	14 Aug 2023	13,782
KRAFT ROBERT O Director	Conversion of Exercise of derivative security at price 26.44 per share.	Direct	364,396	14 Aug 2023	13,782
BRADY KEVIN M. Chief Financial Officer	Sale at price 255.00 per share.	Direct	1,785,000	31 Jul 2023	7,000
BRADY KEVIN M. Chief Financial Officer	Conversion of Exercise of derivative security at price 90.65 per share.	Direct	906,500	31 Jul 2023	10,000
EWALD STEPHEN P General Counsel	Sale at price 254.39 per share.	Direct	5,558,422	27 Jul 2023	21,850
EWALD STEPHEN P General Counsel	Conversion of Exercise of derivative security at price 107.93 per share.	Direct	2,358,270	27 Jul 2023	21,850
KRAFT ROBERT O Director		Direct		30 Jun 2023	94
CARLEY BRIAN T Director		Direct		30 Jun 2023	103
MCCARTHY CORNELIUS P. III Director		Direct		30 Jun 2023	82
CARLEY BRIAN T Director	Conversion of Exercise of derivative security at price 23.00 per share.	Direct	170,200	15 Jun 2023	7,400
TROENDLE AUGUST J Chief Executive Officer	Sale at price 220.85 per share.	Indirect	10,898,285	08 Jun 2023	49,347
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 220.85 per share.	Direct	10,898,285	08 Jun 2023	49,347
TROENDLE AUGUST J Chief Executive Officer	Sale at price 220.46 - 223.05 per share.	Indirect	37,544,581	07 Jun 2023	169,005
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 220.46 - 223.05 per share.	Direct	37,544,581	07 Jun 2023	169,005
TROENDLE AUGUST J Chief Executive Officer	Sale at price 221.83 per share.	Indirect	7,020,476	25 Apr 2023	31,648
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 221.83 per share.	Direct	7,020,476	25 Apr 2023	31,648
KRAFT ROBERT O Director		Direct		31 Mar 2023	94
CARLEY BRIAN T Director		Direct		31 Mar 2023	104
MCCARTHY CORNELIUS P. III Director		Direct		31 Mar 2023	82
BRADY KEVIN M. Chief Financial Officer	Sale at price 227.09 - 229.30 per share.	Direct	457,840	16 Nov 2022	2,000
GEIGER JESSE J President	Sale at price 230.00 per share.	Direct	1,610,000	15 Nov 2022	7,000
GEIGER JESSE J President	Conversion of Exercise of derivative security at price 28.32 per share.	Direct	198,240	15 Nov 2022	7,000
KRAFT ROBERT O Director	Sale at price 221.42 per share.	Direct	2,132,275	01 Nov 2022	9,630
KRAFT ROBERT O Director	Conversion of Exercise of derivative security at price 23.00 per share.	Direct	221,490	01 Nov 2022	9,630
EWALD STEPHEN P General Counsel	Sale at price 220.53 per share.	Direct	1,433,445	27 Oct 2022	6,500
EWALD STEPHEN P General Counsel	Conversion of Exercise of derivative security at price 32.05 per share.	Direct	208,325	27 Oct 2022	6,500
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 154.59 per share.	Indirect	8,877,485	22 Sept 2022	57,426
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 154.59 per share.	Direct	8,877,485	22 Sept 2022	57,426
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 155.14 - 161.63 per share.	Indirect	29,814,076	21 Sept 2022	188,238
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 155.14 - 161.63 per share.	Direct	29,814,076	21 Sept 2022	188,238
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 149.58 - 153.48 per share.	Indirect	23,796,527	19 Sept 2022	156,635
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 149.58 - 153.48 per share.	Direct	23,796,527	19 Sept 2022	156,635
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 152.66 - 153.11 per share.	Indirect	19,115,517	15 Sept 2022	125,032
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 152.66 - 153.11 per share.	Direct	19,115,517	15 Sept 2022	125,032
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 157.12 - 167.58 per share.	Indirect	20,298,778	13 Sept 2022	125,031
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 157.12 - 167.58 per share.	Direct	20,298,778	13 Sept 2022	125,031
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 157.65 - 164.33 per share.	Indirect	18,210,223	09 Sept 2022	113,114
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 157.65 - 164.33 per share.	Direct	18,210,223	09 Sept 2022	113,114
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 147.59 - 150.72 per share.	Indirect	16,871,519	07 Sept 2022	113,114
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 147.59 - 150.72 per share.	Direct	16,871,519	07 Sept 2022	113,114
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 144.52 - 144.98 per share.	Indirect	13,143,379	02 Sept 2022	90,790
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 144.52 - 144.98 per share.	Direct	13,143,379	02 Sept 2022	90,790
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 145.00 per share.	Indirect	1,207,850	18 Jul 2022	8,330
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 145.00 per share.	Direct	1,207,850	18 Jul 2022	8,330
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 144.59 per share.	Indirect	3,222,911	14 Jul 2022	22,290
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 144.59 per share.	Direct	3,222,911	14 Jul 2022	22,290
EWALD STEPHEN P General Counsel	Conversion of Exercise of derivative security at price 32.05 per share.	Direct	32,050	06 May 2022	1,000
TROENDLE AUGUST J Chief Executive Officer	Conversion of Exercise of derivative security at price 90.65 per share.	Direct	9,065,000	01 Mar 2022	100,000
BURWIG SUSAN ELIZABETH Officer	Conversion of Exercise of derivative security at price 28.32 per share.	Direct	351,168	23 Feb 2022	12,400
DAVENPORT FRED B JR Director	Purchase at price 145.80 per share.	Indirect	72,900	17 Feb 2022	500
TROENDLE AUGUST J Chief Executive Officer	Sale at price 213.44 per share.	Indirect	712,463	04 Jan 2022	3,338
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 213.44 per share.	Direct	712,463	04 Jan 2022	3,338
TROENDLE AUGUST J Chief Executive Officer	Sale at price 212.70 - 220.34 per share.	Indirect	10,892,117	03 Jan 2022	50,189
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 212.70 - 220.34 per share.	Direct	10,892,117	03 Jan 2022	50,189
TROENDLE AUGUST J Chief Executive Officer	Sale at price 220.16 - 222.18 per share.	Indirect	9,046,217	29 Dec 2021	40,868
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 220.16 - 222.18 per share.	Direct	9,046,217	29 Dec 2021	40,868
TROENDLE AUGUST J Chief Executive Officer	Sale at price 223.19 - 226.11 per share.	Indirect	13,952,383	27 Dec 2021	62,001
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 223.19 - 226.11 per share.	Direct	13,952,383	27 Dec 2021	62,001
TROENDLE AUGUST J Chief Executive Officer	Sale at price 215.17 - 220.50 per share.	Indirect	12,492,358	22 Dec 2021	57,093
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 215.17 - 220.50 per share.	Direct	12,492,358	22 Dec 2021	57,093
TROENDLE AUGUST J Chief Executive Officer	Sale at price 212.57 - 213.59 per share.	Indirect	11,369,488	20 Dec 2021	53,339
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 212.57 - 213.59 per share.	Direct	11,369,488	20 Dec 2021	53,339
TROENDLE AUGUST J Chief Executive Officer	Sale at price 210.22 - 210.28 per share.	Indirect	1,762,420	16 Dec 2021	8,383
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 210.22 - 210.28 per share.	Direct	1,762,420	16 Dec 2021	8,383
TROENDLE AUGUST J Chief Executive Officer	Sale at price 210.20 - 212.13 per share.	Indirect	3,245,629	10 Dec 2021	15,303
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 210.20 - 212.13 per share.	Direct	3,245,629	10 Dec 2021	15,303
TROENDLE AUGUST J Chief Executive Officer	Sale at price 211.78 - 212.89 per share.	Indirect	7,300,943	08 Dec 2021	34,391
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 211.78 - 212.89 per share.	Direct	7,300,943	08 Dec 2021	34,391
TROENDLE AUGUST J Chief Executive Officer	Sale at price 211.48 per share.	Indirect	84,592	03 Dec 2021	400
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 211.48 per share.	Direct	84,592	03 Dec 2021	400
TROENDLE AUGUST J Chief Executive Officer	Sale at price 210.79 - 211.57 per share.	Indirect	6,920,359	02 Dec 2021	32,732
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 210.79 - 211.57 per share.	Direct	6,920,359	02 Dec 2021	32,732
TROENDLE AUGUST J Chief Executive Officer	Sale at price 210.29 - 212.10 per share.	Indirect	2,611,019	30 Nov 2021	12,312
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 210.29 - 212.10 per share.	Direct	2,611,019	30 Nov 2021	12,312
TROENDLE AUGUST J Chief Executive Officer	Sale at price 210.99 - 213.26 per share.	Indirect	6,288,735	26 Nov 2021	29,649
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 210.99 - 213.26 per share.	Direct	6,288,735	26 Nov 2021	29,649
TROENDLE AUGUST J Chief Executive Officer	Sale at price 212.64 - 224.33 per share.	Indirect	16,337,315	23 Nov 2021	74,185
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 212.64 - 224.33 per share.	Direct	16,337,315	23 Nov 2021	74,185
KING THOMAS C. Director	Sale at price 226.63 per share.	Direct	39,887	03 Nov 2021	176
KING THOMAS C. Director	Conversion of Exercise of derivative security at price 75.63 per share.	Direct	37,815	03 Nov 2021	500
BRADY KEVIN M. Chief Financial Officer	Sale at price 226.50 per share.	Direct	283,125	02 Nov 2021	1,250
BRADY KEVIN M. Chief Financial Officer	Conversion of Exercise of derivative security at price 90.65 per share.	Direct	113,312	02 Nov 2021	1,250
EWALD STEPHEN P General Counsel	Sale at price 209.13 per share.	Direct	2,091,300	26 Oct 2021	10,000
EWALD STEPHEN P General Counsel	Conversion of Exercise of derivative security at price 90.65 per share.	Direct	906,500	26 Oct 2021	10,000
GEIGER JESSE J President	Sale at price 211.36 per share.	Direct	2,113,600	26 Oct 2021	10,000
GEIGER JESSE J President	Conversion of Exercise of derivative security at price 28.32 per share.	Direct	283,200	26 Oct 2021	10,000
KEATING ASHLEY M. Director	Sale at price 210.00 per share.	Direct	420,000	26 Oct 2021	2,000
KEATING ASHLEY M. Director	Conversion of Exercise of derivative security at price 54.99 per share.	Direct	109,980	26 Oct 2021	2,000
TROENDLE AUGUST J Chief Executive Officer	Sale at price 191.82 - 191.85 per share.	Indirect	5,916,252	03 Sept 2021	30,838

NIKKEI 22538,385.73+29.67(+0.08%)

HANG SENG19,073.71-41.35(-0.22%)

CRUDE OIL78.84+0.82(+1.05%)

GOLD FUTURES2,393.20+33.30(+1.41%)

DOW39,908.00+349.89(+0.88%)

Bitcoin GBP52,042.25+3,493.90(+7.20%)

How to claim expenses at work without breaking the rules

Medpace Holdings, Inc. (MEDP)

Insider transactions

Insider transactions reported - last two years

NIKKEI 225
38,385.73
+29.67(+0.08%)

HANG SENG
19,073.71
-41.35(-0.22%)

CRUDE OIL
78.84
+0.82(+1.05%)

GOLD FUTURES
2,393.20
+33.30(+1.41%)

DOW
39,908.00
+349.89(+0.88%)

Bitcoin GBP
52,042.25
+3,493.90(+7.20%)